AcceleDev: Advancing Innovation and Efficiency in Unnatural Amino Acid (UAA) Synthesis
This whitepaper, AcceleDev: Advancing Innovation and Efficiency in Unnatural Amino Acid (UAA) Synthesis, explores the growing impact of UAAs in next-generation pharmaceuticals, highlighting their role in improving drug performance, stability, and targeted delivery. It outlines the expanding global market, projected to surpass $12 billion by 2032, while addressing key challenges—cost, scalability, and regulatory barriers—that hinder commercialization. AcceleDev’s proven expertise in cost-effective and scalable UAA synthesis is showcased through detailed case studies, demonstrating successful outcomes in green chemistry, high-yield processes, and complex molecule production. With over 10,000 completed synthesis projects and robust regulatory readiness, AcceleDev positions itself as a critical partner for biotech and pharma companies aiming to bring innovative UAA-based therapies to market.
AcceleDev Chemical L.L.C.
-
Country/Region:United States
-
On CPHI since:2024
-
Certificates:1
-
Employees:50 - 99
Other Content from AcceleDev Chemical L.L.C. (4)
-
News Learn About AcceleDev's New Jersey US R&D Site and Four China Operations
AcceleDev continues to expand its global capabilities, providing tailored solutions for clients worldwide. In addition to our New Jersey US R&D site, we also have the following China operations:
• Shanghai - R&D Center
• Jiangyin - Scale-up & commercial production
• Dalian - Scale-up & commercial production
• Nanjing - Sourcing & supply chain management -
News Expanding our R&D Excellence Globally in Shanghai
AcceleDev proudly supports your pharmaceutical innovation with our state-of-the-art facilities in Cranbury, NJ and Shanghai, China. -
News Meet Dave Tschaen, Ph.D. our CSO at AcceleDev
Dave's journey in pharmaceutical process chemistry has been remarkable, and we are grateful to have someone with his breadth of experience leading our team of chemists. Dave's passion for science led him to pursue a Ph.D. at Penn State University, where he had the privilege of working with Professor Steve Weinreb. After completing his doctorate, Dave found his way to Merck Research Labs in New Jersey, where he spent a productive 30 years in the Process Chemistry Department -
News AcceleDev Chemical LLC Unveils New 5000 Sq. Ft. R&D/GMP Production Site in Cranbury, New Jersey
Cranbury, NJ – July 9, 2024 – AcceleDev Chemical LLC, a global leader in custom synthesis services, proudly announces the opening of its state-of-the-art 5000 square foot R&D and GMP production facility located at 1 Duncan Drive, Cranbury, New Jersey.